RDY Non Current Assets Total vs Long Term Debt Analysis

RDY Stock  USD 13.60  0.39  2.79%   
Dr Reddys financial indicator trend analysis is much more than just examining Dr Reddys Laboratories latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Dr Reddys Laboratories is a good investment. Please check the relationship between Dr Reddys Non Current Assets Total and its Long Term Debt accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Dr Reddys Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Non Current Assets Total vs Long Term Debt

Non Current Assets Total vs Long Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Dr Reddys Laboratories Non Current Assets Total account and Long Term Debt. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Dr Reddys' Non Current Assets Total and Long Term Debt is -0.08. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of Dr Reddys Laboratories, assuming nothing else is changed. The correlation between historical values of Dr Reddys' Non Current Assets Total and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Dr Reddys Laboratories are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Non Current Assets Total i.e., Dr Reddys' Non Current Assets Total and Long Term Debt go up and down completely randomly.

Correlation Coefficient

-0.08
Relationship DirectionNegative 
Relationship StrengthInsignificant

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Long Term Debt

Long-term debt is a debt that Dr Reddys Laboratories has held for over one year. Long-term debt appears on Dr Reddys Laboratories balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Dr Reddys Laboratories balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.
Most indicators from Dr Reddys' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Dr Reddys Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Dr Reddys Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
At this time, Dr Reddys' Tax Provision is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 972 M in 2025, whereas Selling General Administrative is likely to drop slightly above 66 B in 2025.
 2022 2023 2024 2025 (projected)
Gross Profit203.0B163.6B188.1B197.6B
Total Revenue245.9B279.2B321.0B337.1B

Dr Reddys fundamental ratios Correlations

0.990.970.980.10.970.49-0.09-0.150.931.00.970.890.95-0.060.92-0.170.98-0.040.930.980.910.970.980.980.12
0.990.940.990.220.940.430.03-0.190.950.990.920.860.910.050.86-0.130.940.070.870.950.930.970.950.940.26
0.970.940.91-0.111.00.56-0.18-0.160.840.961.00.90.99-0.210.97-0.231.0-0.110.970.990.810.90.990.99-0.05
0.980.990.910.290.910.40.02-0.160.970.990.890.860.870.10.83-0.090.910.070.840.930.950.980.930.910.3
0.10.22-0.110.29-0.11-0.370.620.050.350.15-0.150.07-0.20.84-0.280.47-0.10.58-0.24-0.040.360.25-0.04-0.110.87
0.970.941.00.91-0.110.54-0.23-0.130.850.961.00.90.99-0.220.97-0.251.0-0.150.970.990.830.910.990.99-0.06
0.490.430.560.4-0.370.54-0.45-0.30.420.460.580.30.6-0.510.63-0.40.56-0.380.50.50.290.480.540.57-0.3
-0.090.03-0.180.020.62-0.23-0.450.12-0.08-0.06-0.230.02-0.270.79-0.330.64-0.20.84-0.27-0.12-0.08-0.1-0.14-0.20.56
-0.15-0.19-0.16-0.160.05-0.13-0.30.12-0.24-0.17-0.130.18-0.160.38-0.110.59-0.130.07-0.06-0.08-0.26-0.25-0.18-0.15-0.14
0.930.950.840.970.350.850.42-0.08-0.240.940.830.740.810.070.76-0.170.85-0.010.760.850.980.990.880.850.33
1.00.990.960.990.150.960.46-0.06-0.170.940.950.870.93-0.030.9-0.180.960.00.910.960.920.970.970.960.19
0.970.921.00.89-0.151.00.58-0.23-0.130.830.950.891.0-0.250.98-0.261.0-0.160.980.990.790.890.990.99-0.1
0.890.860.90.860.070.90.30.020.180.740.870.890.850.110.840.150.90.040.880.940.730.780.890.880.01
0.950.910.990.87-0.20.990.6-0.27-0.160.810.931.00.85-0.310.99-0.30.99-0.210.980.970.780.870.970.99-0.15
-0.060.05-0.210.10.84-0.22-0.510.790.380.07-0.03-0.250.11-0.31-0.360.84-0.210.64-0.3-0.120.090.0-0.17-0.220.68
0.920.860.970.83-0.280.970.63-0.33-0.110.760.90.980.840.99-0.36-0.30.97-0.270.990.950.720.830.940.98-0.23
-0.17-0.13-0.23-0.090.47-0.25-0.40.640.59-0.17-0.18-0.260.15-0.30.84-0.3-0.230.38-0.25-0.14-0.16-0.22-0.22-0.240.21
0.980.941.00.91-0.11.00.56-0.2-0.130.850.961.00.90.99-0.210.97-0.23-0.130.970.990.820.910.990.99-0.06
-0.040.07-0.110.070.58-0.15-0.380.840.07-0.010.0-0.160.04-0.210.64-0.270.38-0.13-0.22-0.06-0.05-0.03-0.06-0.130.63
0.930.870.970.84-0.240.970.5-0.27-0.060.760.910.980.880.98-0.30.99-0.250.97-0.220.960.740.820.940.97-0.2
0.980.950.990.93-0.040.990.5-0.12-0.080.850.960.990.940.97-0.120.95-0.140.99-0.060.960.820.90.990.98-0.01
0.910.930.810.950.360.830.29-0.08-0.260.980.920.790.730.780.090.72-0.160.82-0.050.740.820.960.840.820.35
0.970.970.90.980.250.910.48-0.1-0.250.990.970.890.780.870.00.83-0.220.91-0.030.820.90.960.920.910.28
0.980.950.990.93-0.040.990.54-0.14-0.180.880.970.990.890.97-0.170.94-0.220.99-0.060.940.990.840.920.980.0
0.980.940.990.91-0.110.990.57-0.2-0.150.850.960.990.880.99-0.220.98-0.240.99-0.130.970.980.820.910.98-0.06
0.120.26-0.050.30.87-0.06-0.30.56-0.140.330.19-0.10.01-0.150.68-0.230.21-0.060.63-0.2-0.010.350.280.0-0.06
Click cells to compare fundamentals

Dr Reddys Account Relationship Matchups

Dr Reddys fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets265.5B296.7B322.9B387.5B445.6B467.9B
Other Current Liab45.3B48.3B53.5B58.1B66.8B70.2B
Total Current Liabilities81.5B97.8B85.7B96.0B110.4B69.8B
Total Stockholder Equity175.0B190.5B232.9B280.6B322.6B338.8B
Retained Earnings157.9B175.7B215.6B265.3B305.0B320.3B
Accounts Payable12.7B16.0B17.9B21.5B24.8B14.3B
Cash14.8B14.9B5.8B7.1B8.2B13.6B
Other Assets14.8B11.6B13.7B7.1B8.2B8.6B
Long Term Debt0.06.3B5.7B3.8B4.4B3.5B
Short Term Investments19.7B29.5B61.0B74.4B85.5B89.8B
Inventory45.4B50.9B48.7B63.6B73.1B76.7B
Total Liab90.5B106.1B90.0B107.0B123.0B89.6B
Intangible Assets35.6B27.2B30.7B37.0B42.5B24.7B
Property Plant Equipment52.3B57.1B62.2B66.3B76.2B80.1B
Short Long Term Debt Total30.3B33.8B13.5B20.0B23.0B41.6B
Other Liab3.5B3.1B2.7B2.5B2.9B3.1B
Property Plant And Equipment Net57.1B62.2B56.5B76.9B88.4B55.3B
Current Deferred Revenue2.0B2.6B2.0B1.4B1.3B1.2B
Net Debt15.5B19.0B7.7B12.9B14.8B27.4B
Non Current Assets Total117.2B115.5B118.6B139.5B160.4B98.4B
Non Currrent Assets Other952M948M12.7B16.1B18.5B19.5B
Cash And Short Term Investments34.6B44.4B66.7B81.5B93.7B98.4B
Net Receivables49.6B66.8B72.5B80.3B92.3B48.4B
Good Will4.6B4.4B5.5B4.3B4.9B6.5B
Common Stock Shares Outstanding831.6M831.7M831.9M833.5M958.6M1.0B
Liabilities And Stockholders Equity265.5B296.7B322.9B387.5B445.6B223.8B
Non Current Liabilities Total9.0B8.3B4.3B10.9B12.6B20.2B
Other Current Assets18.6B19.8B21.3B22.7B26.1B27.4B
Other Stockholder Equity8.2B8.4B10.3B10.4B9.4B9.0B
Total Current Assets148.2B181.1B204.3B248.0B285.3B299.5B
Accumulated Other Comprehensive Income1.3B1.1B1.3B4.0B3.6B3.4B
Short Term Debt24.0B28.1B12.2B14.0B16.1B27.0B
Property Plant And Equipment Gross57.1B142.0B152.3B170.1B153.1B145.5B
Net Tangible Assets91.9B123.3B134.8B158.9B182.7B102.9B
Long Term Investments8.3B8.0B6.1B5.3B6.0B4.6B
Short Long Term Debt24.0B28.1B12.2B12.7B11.5B16.6B
Long Term Debt Total1.3B6.3B5.7B1.3B1.2B1.1B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.